Lynx Analytics

LynxKite, the GPU-accelerated AI platform from Lynx Analytics, is co-sponsoring the AAAI-26 workshop “AI in Drug Discovery: From Methods to Molecules” together with our cloud partner Nebius. Taking place on January 26 at #SingaporeEXPO, as part of the 40th Annual AAAI Conference on Artificial Intelligence (AAAI-26), the workshop connects algorithmic AI innovations with real-world drug discovery challenges, focusing on rigorous approaches to bottlenecks like target identification, chemical space exploration, and translational models that can help de-risk development. It will bring together experts across AI, computational life sciences, and pharma to spark cross-disciplinary exchange and shape what’s next in the field. We’re looking forward to the conversations that emerge from a day dedicated to exploring the advances of AI in drug discovery. James Lu Roland G. Huber Ilya Burkov Petra SCHNEIDER Gyorgy Lajtai Daniel Darabos Abhik S. #Nebius #LynxKite2000MM #LynxKite #AAAI26 #AIDD #DrugDiscovery #AI #Pharma

At Lenovo TechDay ’26, our CEO, Gyorgy Lajtai took the stage to share how LynxKite 2000:MM is helping teams move from complex data, language and biological language models, to decisions that actually scale in the real world. LynxKite 2000:MM is supporting enterprise data science teams in orchestrating complex networks of data through a simple UI that helps with GPU-native NIM processing into simple AI systems that users can trust and use every day. Big thanks to Lenovo and NVIDIA for the opportunity to be part of the conversation and for hosting such a strong platform for applied AI and enterprise innovation. Marton Szel Gábor Benedek Krisheno R Pei Yi Pang Benjamin Chan Tricia Sim

We’re proud to introduce Lumen, our new Agentic AI framework designed specifically for pharma and biotech decision-making. https://lnkd.in/gAsapxGA Lumen brings together best practices from real deployments and enables AI agents across commercial and medical use cases, from forecasting explanations to persona generation and strategic planning support. A standout example is IlluminAI, built in collaboration with AstraZeneca’s International Oncology team, where teams can ask natural-language questions and get insights grounded in forecast models and revenue data — complete with citations for transparency and audit-readiness. Excited for what’s next as we help life sciences organizations deploy responsible AI at scale. Christos Georgiou Arash Marco Haddadi Ankit Agrawal #AgenticAI #LifeSciences #PharmaInnovation #AIinPharma

A Year of Good Work and Great Partnerships — here’s our 2025 wrap-up: https://lnkd.in/g3rQUeCn As 2025 winds down, we want to wish you and your loved ones a joyful holiday season — and say a heartfelt thank you for being part of the Lynx Analytics community. This year reminded us of something simple but powerful: good work really does come from good people. We felt that in every conversation, project, brainstorm, and “wait… what if we tried this?” moment. Whether we worked closely together or simply exchanged ideas along the way, we’re grateful for the trust, curiosity, and good energy you brought into our shared work. Across industries, clients tell us they value how we work — with flexibility, creativity, and a genuinely high-touch approach to understanding each team’s goals. Those qualities shaped everything we delivered in 2025, and they’ll continue to guide us into 2026.

Happy to be a sponsor at ESMO Asia 2025 — championing how data and decision-support can enable better coordination between clinicians, diagnostics, and commercial teams. A few reflections from the lung and breast cancer tracks: • Precision oncology is now table stakes – EGFR is reshaping lung cancer management across stages, ADCs are redefining breast cancer, and biomarker-driven decisions are becoming routine practice. • The conversation is shifting from “What’s the best drug?” to “What’s the right sequence for this patient, at this point in their journey?” • MDTs, biomarker strategy and data integration are now as critical as the therapies themselves. • The focus is expanding beyond trial results to include how fast patients are diagnosed, how reliably they access care, and how consistently treatments are delivered in the real world. AI also featured prominently — not as hype, but as infrastructure: enabling smarter trial design, faster insight generation from real-world data, better biomarker workflows, and more scalable decision support for clinicians and pharma teams alike. The next phase isn’t just about more innovation. It’s about making innovation work, at scale, for patients. #esmo #esmo2025 #esmoasia2025

Thanksgiving reminds us that when individuals unite, remarkable things happen — just as agentic AI combines specialized agents to unlock powerful insights in life sciences. That’s precisely what Lumen by Lynx Analytics brings: - Unified data: Connecting unstructured docs, CRM data, external feeds, RWE, etc. into a single foundation - Agentic AI workflows: Building blocks that assemble specialized agents for medical, commercial, and operational needs - Specialized insights: Supporting medical, commercial, and marketing teams with context-aware intelligence embedded directly into workflows Wishing everyone a Happy Thanksgiving! https://lnkd.in/g7AMTGky #thanksgiving #happythanksgiving

Our customer Lynx Analytics bridges industry and tech expertise to deliver AI-powered solutions to enterprises across life sciences, telecom, retail and finance. The team uses Nebius’ elastic AI infra to accelerate delivery across projects and maintain high GPU utilization, keeping performance and costs optimized. Its data science tool, LynxKite 2000:MM, helps domain experts connect complex datasets and deploy predictive Graph AI workloads ranging from single-GPU experiments to 1,000+ units. Read the full story: https://lnkd.in/evCY6MFa #CustomerStories #CaseStudies #GPUs #AICloud

At AI Week Frankfurt, we explored how Agentic AI and knowledge graphs are paving the way for the next era of intelligent, connected pharma ecosystems. Daniel Darabos presented how AI agents can evolve beyond single-task chatbots — forming adaptive, networked systems capable of managing specialized skills and reasoning collaboratively. Marcell Németh expanded on how dynamic knowledge graphs form the foundation of these agentic workflows — connecting structured and unstructured life sciences data to deliver real-time, context-aware insights across therapeutic areas and markets. At Lynx Analytics, our mission is to help life sciences organizations connect data, knowledge, and strategy — enabling teams to plan smarter, align faster, and make evidence-based decisions across the product lifecycle. A big thank you to Polarise and Nils Herhaus for inviting us to speak at their workshop during Frankfurt AI Week. Exciting discussions, inspiring peers, and a shared vision of building AI systems that drive measurable scientific and commercial impact.

At the INSEAD AI50 San Francisco event, the conversations weren’t about chasing hype—they were about making AI enduring, trusted, and measurable. Our COO, Amit Akhelikar, joined fellow INSEAD leaders to emphasize a core principle: AI only creates impact when adoption is real and outcomes are visible. Key themes that stood out: Defensibility now comes from consistent usage and retention, not just technical novelty. Enterprise AI succeeds when outputs are reliable, grounded, and tied directly to business results. Trust, governance, and customer success need to be part of the build from the very beginning. Celebrating the INSEAD AI50 honorees underscored how alumni are driving AI progress across research, startups, investing, and enterprise—making it practical, not theoretical. Victoria (Vic) Woo, Ph.D. Robert Maciejko, Fabio Valle, Miklos Sarvary, Olga Lyudovyk, Peter Zubcsek, Gyorgy Lajtai, Zsolt Katona, Gábor Benedek, Dan Florea, Adrienne Lee, Jorge Iglesias García, Jeroen Lievens

Lynx Analytics is proud to be the title sponsor of the upcoming INSEAD AI Forum Americas, hosted at the INSEAD San Francisco Hub on September 25–26. Our connection to INSEAD runs deep: Lynx Analytics was founded by INSEAD students and professors, and today our CEO Gyorgy Lajtai, COO Amit Akhelikar, and most of our Board Members are proud INSEAD alumni or former faculty. As part of the program, Amit Akhelikar will deliver the opening remarks on Thursday, September 25, to help set the stage for two days of discussions on the impact of AI in business and society. For us, supporting this event is not only about sharing insights on AI—it’s about honoring the world-class institution and academic community that shaped us. If you’re in San Francisco, we’d love to see you there. If not, keep an eye out—we’ll share highlights and key takeaways from the forum. #AI INSEAD Alumni #aiforumamericas Victoria (Vic) Woo, Ph.D.